- ￥220 - 3488
- TargetMol
- T4498
- 2026年07月07日
2 年钻石会员
企业认证
相关产品推荐更多 >
![化合物 2H-Naphth[2′,1′:4,5]indeno[1,2-d][1,3]dioxole, pregn-4-ene-3,20-dione deriv【144459-71-2】](https://img1.dxycdn.com/p/s14/2026/0707/126/6944157965943344702.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- CAS号：
49763-96-4
- 规格：
1mLx10mM(inDMSO)/2mg/5mg/10mg/25mg/50mg/100mg/200mg
| 规格： | 1mLx10mM(inDMSO) | 产品价格： | ￥333.0 |
|---|---|---|---|
| 规格： | 2mg | 产品价格： | ￥220.0 |
| 规格： | 5mg | 产品价格： | ￥330.0 |
| 规格： | 10mg | 产品价格： | ￥518.0 |
| 规格： | 25mg | 产品价格： | ￥1056.0 |
| 规格： | 50mg | 产品价格： | ￥1464.0 |
| 规格： | 100mg | 产品价格： | ￥2376.0 |
| 规格： | 200mg | 产品价格： | ￥3488.0 |
Product Introduction
Bioactivity
| 名称 | Stiripentol |
| 描述 | Stiripentol (BCX2600) (STP) is an anticonvulsant agent, which can inhibit N-demethylation of CLB to NCLB mediated by CYP3A4 (noncompetitively) and CYP2C19 (competitively) with Ki of 1.59/0.516 μM and IC50 of 1.58/3.29 μM, respectively. |
| 细胞实验 | The inhibition constants (apparent Ki) of Stiripentol (STP) for CLB demethylation by CYP3A4 and CYP2C19 are determined using various concentrations of CLB (2, 10, 20, 40, 60, and 100 μM) with increasing concentrations of Stiripentol (STP) (0, 0.5, 1, 2, and 5 μM). Concerning NCLB hydroxylation by CYP2C19, the apparent Ki is similarly determined with different concentrations of NCLB (1.5, 4, 6, 8, 12, and 14 μM) and STP (0, 0.1, 0.5, 1, and 2 μM). IC50 values are determined by coincubation of the substrate at the concentration in the range of the therapeutic plasma concentrations (2 μM CLB or 14 μM NCLB) with increasing concentrations of Stiripentol (STP) (0.001-10 μM) [1]. |
| 动物实验 | Two age groups, p1M (n=18, age 4 weeks) and p5M (n=18, age 5-10 months), of Scn1aRX/+ mice are assigned in this experiment. Both groups are divided randomly into three subgroups (n=6), and each subgroup is administered Stiripentol (STP) (300 mg/kg) alone, CLB (6.62 mg/kg) alone, or a combination of Stiripentol (STP) (p1M; 150 mg/kg, p5M; 300 mg/kg) and CLB (6.62 mg/kg). All drugs are administered by intraperitoneal injection (i.p.) after a 48-h recovery from baseline seizure study. Blood samples are collected at 1 h and 20 min after administration of CLB or STP+CLB for measurement of plasma concentrations of CLB and N-desmethylclobazam, respectively [2]. |
| 体外活性 | Stiripentol (STP) 抑制CLB去甲基化的活性，对于cDNA表达的CYP3A4而言，其抑制效果通过非竞争性抑制模型最佳描述，表观Ki值为1.6 μM；而对于cDNA表达的CYP2C19，则通过竞争性抑制模型描述更为恰当，Ki值为0.52 μM。此外，Stiripentol (STP) 以竞争性抑制的方式，抑制cDNA表达的CYP2C19将NCLB转化为OH-NCLB，Ki值为0.14 μM [1]。 |
| 体内活性 | 在对小鼠进行单一使用Stiripentol（STP）治疗时，其基础体温1（BT1，39.67±1.09°C）与基础体温2（BT2，41.32±1.05°C）之间的差异达到了统计学显著性（t=3.097, p<0.05）。Stiripentol（STP）单疗与CLB单疗间的BT2差异亦具有统计学意义（t=2.615, p<0.05）。在采用Stiripentol（STP）加CLB联合治疗的小鼠中，BT1（40.18±0.58°C）与BT2（43.03±0.49°C）之间的差异显著（t=10.44, p<0.01）[2]。 |
| 存储条件 | Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 5 mg/mL (21.34 mM), Sonication is recommended. DMSO : 250 mg/mL (1067.05 mM), Sonication is recommended. Ethanol : 30 mg/mL (128.05 mM), Sonication is recommended. |
| 关键字 | Stiripentol | Inhibitor | inhibit | Cytochrome P450 | CYPs | CYP3A4 | CYP2C19 | BCX-2600 | BCX 2600 |
| 相关产品 | Naringin | Musk ketone | Ipriflavone | Benzyl alcohol | Clarithromycin | Memantine hydrochloride | Tauroursodeoxycholate | Sudan IV | Naringin dihydrochalcone | Dibenzothiophene | Oxadiazon | Tebuconazole |
| 相关库 | Inhibitor Library | Bioactive Compound Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | EMA Approved Drug Library | Anti-Aging Compound Library | FDA-Approved Drug Library | Anti-Hypertension Compound Library | Orally Active Compound Library | Drug Repurposing Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Drug Library |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
官网有文献
技术资料暂无技术资料 索取技术资料
文献支持
斯利潘托【49763-96-4】
￥220 - 3488
